Scientific Program

Live Stream from Berlin – in Tv Quality

Chat Window: Discuss with us! Send us your questions and comments!

  • Presidential Lectures
  • Pro/Con Debates
  • CMC Panel Discussions
  • Symposia

Breast Cancer

  • Surgical Topics of Breast Surgery and Reconstruction
    and Presentation of Surgery Videos
  • CDK4/6 Inhibitors: Update on Survival Data in the
    Metastatic Setting and Efficacy in the Adjuvant Setting
  • Immune Checkpoint Therapies for ER+ Breast Cancer:
    New Evidence
  • New ER Targeted Therapies: SERDs, SERMs, PROTACs
    and SERCAs
  • ADCs: When, Which, for Whom?
  • Hormone Replacement Therapy: Newer Evidence
  • New Vaccine Approaches for Prevention of Breast Cancer

Cervical Cancer

  • Cervical Cancer Management: Yesterday, Today,
    Tomorrow
  • Radical Hysterectomy, Simple Hysterectomy, or
    Cone Biopsy in Early-stage Cervical Cancer
  • Surgery, Radiochemotherapy, or Incorporation
    Immunotherapy in Primary Cervical Cancer?
  • Newest Options in Cervical Cancer
  • The Most Challenging Case from the Clinical Routine
  • Management of New Side Effects in Cervical Cancer
    Management (Acute, Delayed, and Late)

Ovarian Cancer

  • Ovarian Cancer Management: Yesterday, Today,
    Tomorrow
  • Best Supportive Care Only or Chemotherapy or a
    Specific Cancer Therapy?
  • HRD-related Therapies: PRIMA vs. Paola vs. Athena vs.
    Ov-43 vs. Duo-O and More …
    What is the Best Strategy?
  • Management of New Side Effects in Ovarian Cancer
    Management (Acute, Delayed, and Late)
  • Lymph Node Resection in Primary and Relapsed Ovarian
    Cancer? New Exclusive Data to Revise our Attitude
  • The Most Challenging Case from the Clinical Routine

Endometrial Cancer

  • Endometrial Cancer Management: Yesterday, Today,
    Tomorrow
  • What is Now the Best Therapy for Primary Endometrial
    Cancer?
  • What is the Best Therapy for Relapsed Endometrial
    Cancer? Chemotherapy Pretreated or Naïve?
  • Management of New Side Effects in Endometrial Cancer
    Management (Acute, Delayed, and Late)
  • FIGO Staging
  • Duo-E, Leap-001, NRG-18, RUBY, Garnet, KEYNOTE-158,
    KEYNOTE-775, SIENDO, PALEO and More …
    How to Integrate the Recent Milestone Trials into Clinical
    Practice?
  • The Most Challenging Case from the Clinical Routine

Status: October 2023; may be subject to change

CMC Distilled Berlin